Aesthetic Implants Market Report 2024

The aesthetic implants market size has grown strongly in recent years. It will grow from $4.84 billion in 2023 to $5.21 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period was driven by higher disposable incomes, greater awareness and acceptance, cost-effective procedures, quality healthcare services, and increasing demand from older age groups.

The aesthetic implants market size is expected to see strong growth in the next few years. It will grow to $7.03 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. Anticipated growth in the forecast period will be influenced by evolving regulations, expanding markets, a trend toward minimally invasive procedures, stricter regulatory measures, and an aging population. Key trends expected in this period include advancements in biomaterials, 3D printing, innovations in surgical techniques, integration of digital health technologies, and customized implants.

The increasing prevalence of cosmetic surgeries is expected to drive growth in the aesthetic implant market in the future. These surgeries involve medical procedures that aim to enhance or alter a person's appearance through surgical methods. The growth of cosmetic surgery is fueled by advancements in technology, evolving beauty standards, and greater affordability, responding to individuals' desires for improved appearance and self-confidence. Aesthetic implants are increasingly utilized in these surgeries to enhance physical features, correct deformities, and achieve more natural and durable results, meeting the growing demand for aesthetic enhancements. For example, the British Association of Aesthetic Plastic Surgeons reported a significant increase in cosmetic procedures in 2022, with women accounting for a substantial majority, underscoring the upward trend in demand. Therefore, the rise in cosmetic surgeries is expected to boost the aesthetic implant market.

Leading companies in the aesthetic implant sector are innovating with biocompatible materials such as silicone-based breast implants to improve patient outcomes and safety, offering more realistic results and reducing complications. Silicone-based breast implants are medical devices used in both cosmetic and reconstructive surgery, filled with cohesive silicone gel and encased in a silicone elastomer shell to enhance breast size and shape with a natural appearance and texture. For instance, GC Aesthetics recently launched the LUNA XT, the world's first micro-textured anatomical breast implant approved under the new European Medical Device Regulation (MDR) in April 2024. This implant features a micro-textured surface, cohesive silicone gel, and a high-performance shell, providing advanced support for women undergoing breast reconstruction surgery, whether immediate or delayed. It represents a cutting-edge choice for individuals seeking breast enhancement procedures.

In May 2023, Henry Schein, Inc., a US-based provider of healthcare products and services, acquired the S.I.N. Implant System for an undisclosed sum. This acquisition positions Henry Schein to expand its presence in the rapidly growing global dental implant market, particularly in Brazil and other emerging markets. S.I.N. Implant System, based in Brazil, specializes in manufacturing cost-effective dental implant solutions. This strategic initiative aligns with Henry Schein's growth strategy for its dental specialties division.

Major companies operating in the aesthetic implants market are AbbVie Inc., 3M Company, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Institut Straumann AG, Integra LifeSciences Holdings Corporation, RTI Surgical Holdings Inc., Establishment Labs Holdings Inc., Silimed Indústria de Implantes Ltda., Sientra Inc., GC Aesthetics plc, Hans Biomed Corp., Sebbin, PMT Corporation, POLYTECH Health & Aesthetics GmbH, AVINENT Implant System, Implantech Associates Inc., Symatese Group, Ideal Implant Incorporated, Biodermis Corporation, Nagor Ltd, CEREPLAS, Surgiform Innovative Surgical Products, Alpha Aesthetics LLC, Lattice Medical.

North America was the largest region in the aesthetic implants market in 2023. The regions covered in the aesthetic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aesthetic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Aesthetic implants are medical devices intended to enhance or modify the appearance of a specific body part for cosmetic purposes. These implants are typically crafted from materials such as silicone, saline, or other biocompatible substances. They are utilized in procedures such as breast augmentation, facial contouring (e.g., cheek or chin implants), buttock augmentation, and other body contouring surgeries. Their purpose is to enhance aesthetic appearance based on individual preferences or medical recommendations.

The primary types of aesthetic implants include breast implants, dental implants, facial implants, and others. Breast implants are medical devices implanted under the breast tissue or chest muscles to increase breast size or reconstruct the breast following mastectomy or injury. These implants can be made from materials such as metals, ceramics, and polymers. They are categorized by biological and gender types, specifically for female and male applications. The end-users typically include hospitals, specialty clinics, and other healthcare facilities.

The aesthetic implants market research report is one of a series of new reports that provides aesthetic implants market statistics, including aesthetic implants industry global market size, regional shares, competitors with an aesthetic implants market share, detailed aesthetic implants market segments, market trends and opportunities, and any further data you may need to thrive in the aesthetic implants industry. This aesthetic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aesthetic implants market consists of sales of implant accessories, supportive cosmetics, and post-operative care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.